Search research articles
Contact Us
Filters
Showing results (561-570 of 792) with videos related to
Page
of 80
Sort By:
Neuropeptides
|
April 1, 1985
Increased affinity of dimeric enkephalins is not dependent on receptor density
R A Lutz, T Costa, R A Cruciani, et al.
Parkinsonism & Related Disorders
|
February 25, 2011
Lateral ventricle volume is poor predictor of post unilateral DBS motor change for Parkinson's disease
Catherine C Price, Christopher Favilla, Jared J Tanner, et al.
Life Sciences
|
January 1, 1990
The potent opioid agonist, (+)-cis-3-methylfentanyl binds pseudoirreversibly to the opioid receptor complex in vitro and in vivo: evidence for a novel mechanism of action
L Band, H Xu, V Bykov, et al.
Psychopharmacology
|
July 2, 2026
Effects of repeated treatment with opioids that vary in mu opioid receptor efficacy on pain-depressed locomotor behavior in mice
Jawaun Harris, Dana R Chambers, Delmis E Hernandez, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 30, 2005
Studies of the biogenic amine transporters. XI. Identification of a 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR12909) analog that allosterically modulates the serotonin transporter
Barbara Nightingale, Christina M Dersch, Terrence L Boos, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 5, 2003
Synthesis and dopamine transporter affinity of chiral 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(2-hydroxypropyl)piperazines as potential cocaine abuse therapeutic agents
Ling-Wei Hsin, Thomas Prisinzano, Chavon R Wilkerson, et al.
The American Journal of Medicine
|
July 1, 1983
Safety and efficacy of intravenous quinidine
C D Swerdlow, J O Yu, E Jacobson, et al.
Journal of Medicinal Chemistry
|
May 1, 1987
Hexahydro-1H-1-pyrindines from acid rearrangement of 9-alkylidene-5-(m-methoxyphenyl)-2-methylmorphans. A new structural type of narcotic antagonists
H Awaya, E L May, M D Aceto, et al.
Journal of Medicinal Chemistry
|
March 8, 2002
Development of long-acting dopamine transporter ligands as potential cocaine-abuse therapeutic agents: chiral hydroxyl-containing derivatives of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine
Ling-Wei Hsin, Christina M Dersch, Michael H Baumann, et al.
JAMA
|
November 13, 1972
Experience in clinical lung transplantation
F J Veith, S K Koerner, J W Hagstrom, et al.
Page
of 80
Search research articles
Search
Showing results (561-570 of 792) with videos related to
Sort By:
Page
of 80
Neuropeptides
|
April 1, 1985
Increased affinity of dimeric enkephalins is not dependent on receptor density
R A Lutz, T Costa, R A Cruciani, et al.
Parkinsonism & Related Disorders
|
February 25, 2011
Lateral ventricle volume is poor predictor of post unilateral DBS motor change for Parkinson's disease
Catherine C Price, Christopher Favilla, Jared J Tanner, et al.
Life Sciences
|
January 1, 1990
The potent opioid agonist, (+)-cis-3-methylfentanyl binds pseudoirreversibly to the opioid receptor complex in vitro and in vivo: evidence for a novel mechanism of action
L Band, H Xu, V Bykov, et al.
Psychopharmacology
|
July 2, 2026
Effects of repeated treatment with opioids that vary in mu opioid receptor efficacy on pain-depressed locomotor behavior in mice
Jawaun Harris, Dana R Chambers, Delmis E Hernandez, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 30, 2005
Studies of the biogenic amine transporters. XI. Identification of a 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR12909) analog that allosterically modulates the serotonin transporter
Barbara Nightingale, Christina M Dersch, Terrence L Boos, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 5, 2003
Synthesis and dopamine transporter affinity of chiral 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(2-hydroxypropyl)piperazines as potential cocaine abuse therapeutic agents
Ling-Wei Hsin, Thomas Prisinzano, Chavon R Wilkerson, et al.
The American Journal of Medicine
|
July 1, 1983
Safety and efficacy of intravenous quinidine
C D Swerdlow, J O Yu, E Jacobson, et al.
Journal of Medicinal Chemistry
|
May 1, 1987
Hexahydro-1H-1-pyrindines from acid rearrangement of 9-alkylidene-5-(m-methoxyphenyl)-2-methylmorphans. A new structural type of narcotic antagonists
H Awaya, E L May, M D Aceto, et al.
Journal of Medicinal Chemistry
|
March 8, 2002
Development of long-acting dopamine transporter ligands as potential cocaine-abuse therapeutic agents: chiral hydroxyl-containing derivatives of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine
Ling-Wei Hsin, Christina M Dersch, Michael H Baumann, et al.
JAMA
|
November 13, 1972
Experience in clinical lung transplantation
F J Veith, S K Koerner, J W Hagstrom, et al.
Page
of 80